Cal-Maine 10-Qquarter ended 2026-08-29

MixedLegal / investigation

Recovering U.S. egg supply crushed conventional-egg pricing; profitable specialty eggs and prepared foods could not offset losses.

Filed 2026-09-30 06:13 ET

Key figures · Q1 FY2027 · period ended 2026-08-29

  • Revenue$539.6MYoY −41.5%QoQ −2.3%
  • Operating income−$82.2MYear ago $249.2MQoQ −39.7%
  • Net income−$58.6MYear ago $199.3MQoQ −63.4%
  • Total assets$3.0BYoY −5.7%QoQ −3.0%
  • Total debtNo debtYear ago $0Previous quarter $0
  • Shareholders' equity$2.6BYoY −4.7%QoQ −2.4%
  • Tangible book value$2.4BYoY −7.6%QoQ −3.5%

How this filing reads

  • Health+0.5Cash and securities totaled $768M, with no revolver borrowings and quarterly operating outflow of $101M.
  • Momentum−0.9Revenue fell 42% to $540M, and net income swung from $199M profit to a $58.6M loss.
  • Outlook−0.5Hen supply reached 319M versus the 312M five-year average, risking prolonged conventional losses.
  • Legal / investigation“New conventional-egg litigation and Washington’s continuing investigation create unquantifiable exposure”

Executive Summary

Cal-Maine’s Q1 FY2027 exposed its sensitivity to egg prices: recovering U.S. supply drove conventional prices down 59% Y/Y, turning last year’s exceptional profitability into a $58.6M net loss. Specialty eggs and prepared foods remained profitable, but neither offset conventional-egg losses, higher corporate costs and expansion-related inefficiencies. Management continues to diversify through branded eggs, acquisitions and prepared-food capacity, although those investments currently consume cash and constrain production. Substantial liquidity provides a cushion, but the investment thesis now depends on price stabilization and execution rather than a return to supply-shortage-driven windfalls; dividends remain suspended pending recovery of cumulative losses.

Key Financial Highlights

Q1 FY2027 covers the 13 weeks ended 8/29/2026; cash flows cover the same period.

Metric Reported result Investor interpretation
Revenue $540M, −42% Y/Y Conventional-egg pricing, not a broad volume collapse, drove the reversal.
Gross profit $0.403M vs $311M Revenue barely covered cost of sales before operating expenses.
Operating income $(82.2)M vs $249M Operating economics deteriorated sharply.
GAAP net income / diluted EPS $(58.6)M / $(1.26) vs $199M / $4.12 A $18.0M income-tax benefit softened the loss.
OCF / FCF $(101)M / $(128)M Cash outflow exceeded the accounting loss; capital expenditures were $26.6M.
Total assets $3.01B, −3.0% since 5/30/2026 The asset base contracted despite continued investment.
Total equity / net tangible assets, including noncontrolling interests $2.58B / $2.39B Tangible backing remains substantial after deducting goodwill and net intangible assets.
Cash and cash equivalents / investment securities $114M / $654M fair value Securities declined 20% since fiscal year-end as investments funded cash needs.
  • Cash conversion: Lower egg prices reduced customer collections; “other adjustments, net” of $(60.7)M also contributed to OCF falling below net income. Net investment-security sales and maturities of $162M helped fund operating outflows and investment spending, rather than cash being generated by operations.
  • Revenue mix: External specialty-egg sales of $229M exceeded conventional-egg sales of $192M, representing 42% and 36% of revenue, respectively; prepared foods contributed $63.0M, or 12%. This mix shift largely reflects conventional-price weakness, not specialty growth.
  • Cost pressure: Unallocated corporate selling, general and administrative expenses increased 53% to $24.6M, mainly from insurance and legal/professional costs. The prior-year quarter also benefited from a $7.49M insurance gain.
  • Capital returns: Quarter-end shares outstanding decreased by ≈0.065M to ≈46.9M, net of issuance, alongside 66,601 shares repurchased. Subsequent repurchases totaled $14.9M; $315M of authorization remained at quarter-end. Cumulative losses of $94.5M must be recovered before the variable dividend can resume.
  • Earnings quality: A $2.50M fair-value reduction lowered acquisition-related contingent consideration to $19.0M; this valuation adjustment is distinct from operating improvement.

Business Developments

Management’s stated strategy is to expand specialty eggs and prepared foods while pursuing disciplined acquisitions and operating efficiencies. The new three-segment presentation makes the diversification challenge clearer: conventional eggs lost $71.0M, while specialty eggs and prepared foods earned $14.9M and $7.84M, respectively.

  • Branded distribution: The $25.0M Eggland’s Best Northeast territory acquisition on 7/10/2026 expanded exclusive branded-egg rights across several northeastern states. The franchise right is indefinite-lived, supporting brand reach but adding impairment exposure rather than amortization expense.
  • Capacity expansion: Recent acquisitions included ≈$129M of Creighton Brothers/Crystal Lake assets and ≈$24.8M of Van’s Foods assets. Prepared-food projects continue through mid-to-late FY2027; temporary production reductions contributed to a 19% decline in sales pounds and a 12% increase in cost per pound.
  • Financial flexibility: A replacement $250M senior unsecured revolving credit facility matures on 8/31/2031. No borrowings were outstanding on 9/30/2026, providing additional flexibility beyond cash and investments.

Risk Assessment

  • Egg-price normalization: U.S. layer hens reached 319M on 9/1/2026, above the five-year average of 312M; recovering supply can prolong conventional-egg losses despite relatively stable company volume.
  • Antitrust exposure: New conventional-egg litigation and Washington’s continuing investigation create unquantifiable exposure; separately, a contested $43.6M joint-and-several processed-egg judgment exceeds Cal-Maine’s $19.6M accrued proportional share.
  • Expansion execution: Lower prepared-food throughput and higher unit costs show that capacity investment can depress earnings before delivering diversification benefits.
  • Disease and input costs: Highly pathogenic avian influenza can disrupt flocks and production, while feed and production costs already increased specialty cost per dozen by 11%.
  • Cash consumption: Continued operating outflows, acquisitions and repurchases could further reduce investment reserves and eventually increase financing needs.

This 10-Q lists no risk factors of its own and refers to the annual report. The risks above come from the rest of this filing. Full list: FY2026 10-K.

Strategic Outlook and Investor Actionables

Management is building a less commodity-dependent business, but diversification must become more profitable before it can materially cushion egg-price cycles.

  • Monitor conventional prices and segment earnings: Stabilizing prices and narrowing losses would support recovery; persistent losses despite stable volume would challenge it.
  • Monitor specialty margins and prepared-food throughput: Higher volumes with declining unit costs would validate expansion spending.
  • Monitor OCF, investment balances and cumulative losses: Improving cash conversion would reduce reliance on securities sales, while recovery of the $94.5M loss balance is the prerequisite for dividends.

Figures are computed from the filing's XBRL data; the summary and scores are written by an AI model reading the filing.

Model 006 · prompt 18882ea63d

Feedback